(3R,4R,5S)-4-Acetamido-5-((4-(benzo[b]thiophen-5-yl)-benzyl)amino)-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic Acid

ID: ALA4276674

Chembl Id: CHEMBL4276674

PubChem CID: 145983190

Max Phase: Preclinical

Molecular Formula: C29H34N2O4S

Molecular Weight: 506.67

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2ccc(-c3ccc4sccc4c3)cc2)[C@H]1NC(C)=O

Standard InChI:  InChI=1S/C29H34N2O4S/c1-4-24(5-2)35-26-16-23(29(33)34)15-25(28(26)31-18(3)32)30-17-19-6-8-20(9-7-19)21-10-11-27-22(14-21)12-13-36-27/h6-14,16,24-26,28,30H,4-5,15,17H2,1-3H3,(H,31,32)(H,33,34)/t25-,26+,28+/m0/s1

Standard InChI Key:  HWQBZWISMHIAKN-ZRRKCSAHSA-N

Alternative Forms

  1. Parent:

    ALA4276674

    ---

Associated Targets(non-human)

Influenza A virus (11224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fibroblast (58 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 506.67Molecular Weight (Monoisotopic): 506.2239AlogP: 5.52#Rotatable Bonds: 10
Polar Surface Area: 87.66Molecular Species: ZWITTERIONHBA: 5HBD: 3
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.21CX Basic pKa: 8.80CX LogP: 2.63CX LogD: 2.62
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.34Np Likeness Score: 0.00

References

1. Zhang J, Murugan NA, Tian Y, Bertagnin C, Fang Z, Kang D, Kong X, Jia H, Sun Z, Jia R, Gao P, Poongavanam V, Loregian A, Xu W, Ma X, Ding X, Huang B, Zhan P, Liu X..  (2018)  Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant.,  61  (22): [PMID:30365885] [10.1021/acs.jmedchem.8b01065]

Source